News
How Edinburgh pioneer behind 'holy grail' gene therapy technology raised £3 million
An Edinburgh-based biotech pioneer behind technology described as the “holy grail for emerging gene therapies” has been given a £3 million funding injection.
Concinnity Genetics - co-founded by Jessica Birt and Matthew Dale - has developed novel control mechanisms using a cutting-edge artificial intelligence (AI) platform and its synthetic biology expertise.
Source: The Scotsman
Cytomos secures £5 million for scale-up
Midlothian-based biotechnology company Cytomos has secured £5 million to scale up production of its cell analysis technology.
Cytomos said that the investment will enable it to drive sales of its first commercial product, Celledonia™, built on its cell analysis technology platform, AuraCyt, which is “already generating significant market traction.”
Cytomos secures £5 million of scale-up investment
Cytomos has raised £5m to scale up production of its cell analysis technology.
New investment will allow the Edinburgh-based biotechnology company to drive sales of its first commercial product, Celledonia, built on its cell-analysis technology platform AuraCyt.
Source: Business Insider